Summary Three hundred and sixty-nine patients in an MRC study of combination chemotherapy and radiotherapy for small-cell lung cancer of limited extent were asked to complete a Daily Diary Card which enabled an assessment of their quality of life to be made during and after treatment. The information derived from the card suggests that although cytotoxic chemotherapy has an adverse effect upon quality of life, this impairment only affects the first 2 or 3 days following each course of treatment, although there is also a small deterioration which may be associated with the 'nadir' effect of the blood counts about 10 days after each course. These results should assist physicians in counselling patients about the likely effects of treatment. Just over half of the patients (196) were subsequently randomised to either a further six courses of maintenance chemotherapy or no further chemotherapy, and it is also shown that the patients allocated to no maintenance chemotherapy experienced a gradually deteriorating quality of life, as opposed to the brief but more severe adverse effects which occurred following each course in the maintenance chemotherapy group; this supports the hypothesis of a palliative effect in this latter group. The findings demonstrate that the Daily Diary Card is a sensitive instrument capable of yielding useful information.
Small-cell lung cancer carries a poor prognosis but is usually highly sensitive to cytoxic chemotherapy and radiotherapy. Such treatment policies aim to control the symptoms of the disease, prolong survival, and will cure a small proportion of the patients. However, although the primary disease and its metastases may be controlled, and therefore the symptoms reduced, the adverse effects of treatment may be unpleasant, and all too often there is little gain in the number of long term survivors. A Medical Research Council (MRC) study of chemotherapy in the treatment of small-cell lung cancer attempted to assess this (MRC Lung Cancer Working Party, 1989) . Since long term survival is uncommon, the patients' quality of life whilst receiving treatment is important. In particular, since the chemotherapy may be toxic it is desirable to limit its duration to the shortest that can achieve maximum benefit. These considerations have led to an increased interest in methods of assessing quality of life, and they are now frequently included in clinical trials. Such assessments may be made by the clinician, a nurse, the patient or a relative; usually, however, they only report a summary of the patient's quality of life since the previous attendance at the hospital or over some similarly long time span. In earlier studies the MRC Lung Cancer Working Party had used standard scales applied by clinicians at such intervals to assess performance status and general health. In this study it was decided to develop a Diary Card to be completed by patients on a daily basis (Figure 1 ) so as to examine the way in which the patient's general health varies during and after a course of treatment. The results from this Daily Diary Card are presented, and the problems associated with developing and applying new instruments for assessing quality of life are discussed. Similar cards are now being used in a number of current MRC studies, and by other groups (Geddes et al., 1990) .
Methods
Patients and outline of study The design of the study is reported in greater detail elsewhere (MRC Lung Cancer Working Party, 1989) . In this paper only those study patients with limited disease are described, since the protocol treatment for patients with extensive disease was different. In essence, patients with small-cell lung cancer were eligible for the study if they were aged 75 years or less, and had 'good performance status', that is were able to get out and about even if activity was restricted. An initial induction period of treatment of six courses of chemotherapy was given, with radiotherapy between courses two and three. Patients who were responding to treatment were then randomly assigned to a policy of maintenance (M) if a questionnaire were used at the time of attending a clinic. differences were found in age, but the patients returning most data appeared to be the healthier ones (Chi-squared for trend, P <0.02 for physicians' assessments of activity and patients' self-assessment of overall conditions, P <0.001 for physicians' assessments of overall condition).
Quality of life
Quality of life charts se from one centre returned no Figure 2 shows the percentage of patients reporting themately, from the statistical point of selves in the worst two grades, namely 4 to 5 (see Table I aPatients' assessment = average over previous 3 weeks, grouped as: I = less than 1.5; 2 = 1.5 to 2.49; 3 = 2.5 to 3.49; 4 = 3.5 or more. aAt each course data were only included if the patient had provided data for all of the following 7 days. similar percentages of patients reported 2 or more days of vomiting. Similarly, no differences between courses were seen in the answers to the other questions on the diary card.
Anxiety preceding a course of treatment Although there was little suggestion from the charts, it was thought possible that patients might become anxious or miserable in the few days prior to a course of treatment. We therefore analysed in more detail the numbers of patients reporting themselves to be anxious during the 7 days prior to the 5th course during the induction period. The fifth course was chosen because by this time the patients are familiar with the effects of the treatment; the sixth course might not be representative, as some of the NoM patients would have already been told that this is their last course. No patterns were evident in the numbers, although it is perhaps likely that a few patients may become more anxious immediately prior to visiting the hospital whilst others may feel relieved to be going back for treatment. Additional analyses of the data preceding other courses showed similar lack of patterns.
Comparison of M and NoM groups
In addition to the graphical representations, it is possible to summarise the data in various numerical ways. Table VIII examines the percentage of days that patients rated themselves in each category during the 6-week period after the end of induction treatment. More M than NoM patientdays were reported in the worse categories (3 to 5) for all questions, which agrees with the quality of life charts in which, after the induction period, the area under the curves is much larger for M patients than for NoM patients. Table IX , using a different style of presentation, gives the number of days that patients graded themselves as having poor overall condition (categories 4, 5). By the second period larger numbers of the M patients felt ill than NoM patients, although initially eight of the 22 NoM patients assessed were in categories 4/5 for at least 5 days.
Discussion

Analysis of Diary Cards
The diary card has produced large amounts of information with the 369 patients returning on average more than 100 days of repeated data, representing a total of nearly 200,000 items of information. A natural method of analysis to consider is to reduce the data for each patient to a few summary scores, such as 'average overall condition'. We have used this approach in some of the tables. However, there are obvious difficulties in using any form of averaging process, especially when attempting to combine severity with duration. For example, is 1 day of feeling very ill followed by a day of feeling very well equivalent to 2 'average' days? Furthermore, if one wishes to use average scores surely it is preferable, not to say far simpler to implement, to ask the patient to carry out the averaging and weighting by posing such questions as 'How have you been feeling since your last course of treatment?'. Compliance Compliance is often a problem with self administered assessments (Baum et al., 1979) , and depends crucially upon the manner in which the patient is introduced to the questionnaire (van Dam et al., 1983) . Such problems are likely to be greater both for a multicentre study as opposed to a single centre study, and for a daily diary card than for a questionnaire completed when the patient attends for treatment. However, reports from many centres suggested that if time was taken to explain that the card has two benefits, namely in assisting with the review of the patients' condition and in helping to investigate the problems of the treatment, most patients were willing to complete cards regularly. This was confirmed by the way that those physicians who most successfully used the card, and who presumably also most encouraged their patients to make full use of it, found that patients made much use of the blank space at the bottom of the card to describe how they felt during their treatment. We observed major differences in the level of patient compliance between centres, again suggesting that much of the problem relates to the way in which the cards were administered and confirming the need to ensure that efforts were made to provide sufficient motivation for the patients. Those centres with additional support staff assigned to clinical trials were likely to obtain higher rates of compliance than other centres. However, the overall levels of compliance were the same in both the M and NoM group, and we therefore believe that bias is unlikely to render tests for differences between the two groups of patients invalid. Patients returning few or none of the cards may differ from patients returning larger numbers; although age and survival did not appear to relate to compliance there did appear to be an association of compliance with the patient's overall condition. In particular, there was a suggestion that healthier patients were more likely to complete cards. However, this effect was present in both groups and is therefore unlikely to bias the results. Thus, notwithstanding the variable level of compliance, we consider the quality of life data collected during this trial to be representative of the patients entered into the study.
Validity
It is generally recognised that validity is of crucial importance in assessing any new scale (e.g. Feinstein et al., 1986; Goldberg & Hillier, 1979; Kaplan et al., 1976; Nunnally, 1978) . Unfortunately, however, there is a growing awareness that for quality of life measurements there is no 'gold standard' against which to compare scales (Boyd et al., 1988; Derogatis & Spencer, 1984; Kaplan et al., 1976; Selby et al., 1984; Till et al., 1984) and that indirect methods must be used. In theory an in-depth psychological interview might seem to be the ideal yardstick, but in the context of a multicentre trial this is usually impractical. More importantly, however, the act of conducting an in-depth interview is very likely to modify a patient's perception of their quality of life (Brinkley, 1985) ; many patients are relieved to be able to discuss how they feel (van Dam et al., 1983; Fallowfield et al., 1987; Clark & Fallowfield, 1986) , and appreciate the interest that is shown in their quality of life.
Instead one can consider comparing the new scale against existing instruments. In this case, however, the current authors would argue that if two scales ask broadly similar questions about, say, overall condition then it would be most surprising if the results obtained from both were not also broadly similar; on the other hand it would be surprising if the results were identical. Furthermore, if the results were identical it would merely demonstrate that the new scale confers no advantages. Thus in general it is of limited interest to compare two different scales, unless the newer one has advantages such as being simpler to administer or providing more useful information. Also, the degree of agreement between self-assessment of health and physician ratings has been found to vary from very litle to very high according to the topic being assessed and it has been suggested that it may be most practical to choose a scale which is not necessarily 'true' in some absolute sense, but rather which is most useful in providing comparative data (Hunt et al., 1980) . Undaunted, however, we compared the results obtained from the clinicians assessment with those from the Daily Diary Card. In order to make the comparisons it was necessary to average the patients' daily scores, which implicitly makes the dubious assumptions that the scales are linear (so that 1 day at grade 2 followed by 1 day at grade 4 is equivalent to 2 days at grade 3), and also that the physicians' assessments represent averages of how the patients have felt since the previous assessment. Although the questions differed slightly in wording and thus were not directly comparable, we nevertheless found reasonable agreement. One particular aspect was of special interest: the patients reported much higher levels of vomiting after their courses of chemotherapy than had been recorded by the physicians. However, the form completed by the physicians did not contain an explicit question about vomiting, but merely a general heading of 'adverse reactions'. Since it is likely that the chemotherapy would induce vomiting in most patients, there seems to be evidence that the physicians were under-reporting the incidence of vomiting whilst the self-assessment with the diary card is likely to be a more accurate representation of what was happening. There was close agreement between the patient's and physician's assessment of activity. Also, there was strong association between the patients' assessments of overall condition and weight loss since the previous visit.
The patients also answered questions about 'mood' and 'anxiety'; these were loosely worded questions and it is in no way claimed that they provide a formal assessment of the analogous psychometric terms; however, we expect the questions to provide information about the patients' perception of their general condition. These scores showed similar associations and patterns as the other measures, and appeared to contribute little additional information. The clear patterns in the charts and their interpretation as described in the results strongly suggest that the diary card is yielding valid data, some of which are not available from less frequent assessments. This claim is also supported by the results in Geddes et al. (1990) , who compared the diary card, in a version very similar to ours, against EORTC and Spitzer quality of life assessments; they concluded that the card succeeded in measuring the more specific variables of the EORTC questionnaire, but did not address all the areas of the Spitzer index.
Sensitivity and reliability The charts show that the diary card was sensitive enough to detect adverse effects of treatment, particularly the large day-to-day changes in general health which occur following a course of chemotherapy. The period of radiotherapy is also apparent, as is the deterioration in health in NoM patients after the end of treatment. The time when blood counts are usually at their nadir is also visible; this also corresponds to the uneven distribution of deaths during chemotherapy, noted elsewhere (MRC Lung Cancer Working Party, 1989; Souhami et al., 1987) , which occurs most often about 10 days after a course. Similarly, the consistency of the effects on successive courses and in both the M and NoM groups supports the proposition that the card yields repeatable, sensitive and reliable data. Geddes et al. (1990) found that the diary card gave reproducible data which reflected the day to day variation in symptoms during chemotherapy in a way which the other questionnaires could not.
In summary, it would appear that the diary card is sufficiently sensitive to detect time and treatment related changes, and is also sufficiently reliable to be able to yield repeatable measurements. The results in the charts, with their natural interpretation, also confirm that the Daily Diary Card appears to be a valid measure of general health.
Consequences ofpoor compliance As commented above, compliance has frequently been found to be a problem in quality of life assessments. What has less often been noted is that lack of compliance in quality of life reporting may lead to serious biases the magnitudes of which are difficult to assess. For example, it may be that patients with poor quality of life will more often refuse to answer or, alternatively, it may be those with favourable quality of life who see little point in reporting how they feel. The former appeared to be the case in our study, and better compliance was obtained in healthier patients. Although the betweengroup comparisons in the present study are likely to remain valid, especially since the compliance levels were similar in the two groups, it is difficult to know how to interpret the results in terms of the overall health of patients. It should also be borne in mind that patients in a clinical trial may not be representative of patients treated under routine conditions. In particular, the patients may have been more closely monitored and supervised, and the very act of completing and returning Diary Cards may have affected the patients' perception of the care and support that was being given. Even with a high level of compliance, it would remain unclear as to how applicable the results obained from a scientific investigation are as an indicator of the quality of life to be expected in future patients undergoing the same policy of treatment. Whilst this is also true for most outcomes from clinical trials in general, it is possible that subjective assessments such as Quality of Life are more strongly influenced.
Quality of life in clinical trials
Patients in clinical trials are often followed-up more closely than those treated in routine practice, and the quality of their treatment may also be better: this frequently leads to al., 1981) , also in the form of Quality-adjusted life years (QALYs) (Williams, 1985; Kind et al., 1982) , but such approaches remain controversial (Smith, 1987) .
Conclusions
In this study there was no clear evidence that extending chemotherapy beyond six courses prolonged survival, although there was a suggestion that it may be beneficial in patients showing a complete response to initial chemotherapy. However, the results from the Diary Card show that most of the adverse side effects appear to be confined to the first few days following a course of chemotherapy, although there is also a small deterioration which may be associated with the 'nadir' effect. This applied to all the dimensions assessed, namely overall condition, physical activity, vomiting, mood and anxiety. These results should assist physicians in discussing the likely effects of treatment with patients, and in counselling them. However, over 50% of the patients retumed less than half of their cards and there appeared to be a slight tendency for better compliance in the healthier patients, possibly suggesting that side effects may have been underestimated. We have also shown that some patients allocated to No Maintenance experienced a gradually deteriorating quality of life, as opposed to the brief but more severe side effects which continued to occur following each course in the Maintenance group. This supports the hypothesis that there was a palliative effect in the M group. We believe the Daily Diary Card has enabled the effects of the treatment to be examined in more detail than by using more conventional methods, and the Medical Research Council Lung Cancer Working Party is continuing to use similar cards in subsequent studies.
